NYSE: AACTAres Acquisition Corp II Stock
$11.26-0.03 (-0.27%)
Updated May 8, 2025
AACT Price
$11.26
Fair Value Price
N/A
Market Cap
$703.75M
52 Week Low
$10.58
52 Week High
$11.29
P/E
26.81x
P/B
-31.93x
P/S
N/A
PEG
2.21x
Dividend Yield
N/A
Revenue
$0.00
Earnings
$25.99M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.05
Operating Cash Flow
-$930k
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AACT's potential to beat the market
- AACT doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
D
AACT
RankedUnranked of 20
RankedUnranked of 20
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.24 | C | |
| $10.45 | C | |
| $10.05 | C |
Be the first to know about important AACT news, forecast changes, insider trades & much more!
AACT News
Overview
Due Diligence Score
–
Industry Average (10)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AACT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AACT ($11.26) is trading above its intrinsic value of $4.09, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AACT is poor value based on its earnings relative to its share price (26.81x), compared to the US market average (24.22x)
P/E vs Market Valuation
AACT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more AACT due diligence checks available for Premium users.
Valuation
AACT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
26.81x
Industry
-27.84x
Market
24.22x
AACT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AACT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
AACT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-31.93x
Industry
-54.63x
AACT price to earnings growth (PEG)
For valuing profitable companies with growth potential
AACT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
AACT's financial health
Profit margin
Revenue
$0.0
Net Income
$6.0M
Profit Margin
0%
AACT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$551.9M
Liabilities
$23.2M
Debt to equity
-1.05
AACT's short-term assets ($1.10M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AACT's long-term liabilities ($22.50M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AACT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AACT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$214.6k
Investing
$0.0
Financing
$0.0
AACT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
AACT vs Shell Company Stocks
Ares Acquisition II Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.